应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FBIO Fortress Biotech Inc.
圣诞节休市 12-24 13:00:00 EST
3.67
+0.07
+1.94%
盘后
3.69
+0.02
+0.52%
16:08 EST
最高
3.68
最低
3.55
成交量
20.46万
今开
3.62
昨收
3.60
日振幅
3.61%
总市值
1.14亿
流通市值
8,629万
总股本
3,104万
成交额
74.52万
换手率
0.87%
流通股本
2,351万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Journey Medical Corporation公布评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果
美股速递 · 12-10
Journey Medical Corporation公布评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果
Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款
美股速递 · 11-17
Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款
Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA
美股速递 · 11-17
Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA
Fortress Biotech及其子公司Urica Therapeutics宣布Crystalys Therapeutics全球III期Dotinurad治疗痛风临床试验首位患者接受治疗
美股速递 · 10-21
Fortress Biotech及其子公司Urica Therapeutics宣布Crystalys Therapeutics全球III期Dotinurad治疗痛风临床试验首位患者接受治疗
Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资
美股速递 · 10-01
Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资
加载更多
公司概况
公司名称:
Fortress Biotech Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。该公司是一家生物制药公司,专注于收购和推进资产,通过产品收入、股权持有以及股息和特许权使用费收入流为股东提升长期价值。
发行价格:
--
{"stockData":{"symbol":"FBIO","market":"US","secType":"STK","nameCN":"Fortress Biotech Inc.","latestPrice":3.67,"timestamp":1766599200000,"preClose":3.6,"halted":0,"volume":204579,"hourTrading":{"tag":"盘后","latestPrice":3.6891,"preClose":3.67,"latestTime":"16:08 EST","volume":2386,"amount":8842.9305,"timestamp":1766610535458},"delay":0,"floatShares":23511081,"shares":31037937,"eps":-0.953861,"marketStatus":"圣诞节休市","change":0.07,"latestTime":"12-24 13:00:00 EST","open":3.62,"high":3.68,"low":3.55,"amount":745219.43231,"amplitude":0.036111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.953861,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766739600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.6,"preHourTrading":{"tag":"盘前","latestPrice":3.65,"preClose":3.6,"latestTime":"09:13 EST","volume":1817,"amount":6512.9660004,"timestamp":1766585593513},"postHourTrading":{"tag":"盘后","latestPrice":3.6891,"preClose":3.67,"latestTime":"16:08 EST","volume":2386,"amount":8842.9305,"timestamp":1766610535458},"volumeRatio":0.626541,"impliedVol":2.64,"impliedVolPercentile":0.976},"requestUrl":"/m/hq/s/FBIO","defaultTab":"news","newsList":[{"id":"1153698516","title":"Journey Medical Corporation公布评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1153698516","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153698516?lang=zh_cn&edition=full","pubTime":"2025-12-10 21:31","pubTimestamp":1765373472,"startTime":"0","endTime":"0","summary":"Journey Medical Corporation公布了评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果,结果已刊登在《皮肤病药物杂志》上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DERM","BK4139","BK4007","FBIO"],"gpt_icon":0},{"id":"1115885695","title":"Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1115885695","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115885695?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:37","pubTimestamp":1763383035,"startTime":"0","endTime":"0","summary":"Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0},{"id":"1126564189","title":"Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1126564189","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126564189?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:33","pubTimestamp":1763382814,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0},{"id":"1130939272","title":"Fortress Biotech及其子公司Urica Therapeutics宣布Crystalys Therapeutics全球III期Dotinurad治疗痛风临床试验首位患者接受治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1130939272","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130939272?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:31","pubTimestamp":1761049870,"startTime":"0","endTime":"0","summary":"Fortress Biotech及其子公司Urica Therapeutics宣布,Crystalys Therapeutics正在进行的全球III期Dotinurad治疗痛风的临床试验首位患者已完成用药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0},{"id":"1158296044","title":"Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1158296044","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158296044?lang=zh_cn&edition=full","pubTime":"2025-10-01 20:06","pubTimestamp":1759320378,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fortressbiotech.com","stockEarnings":[{"period":"1week","weight":0.07},{"period":"1month","weight":0.4392},{"period":"3month","weight":-0.0213},{"period":"6month","weight":1.0165},{"period":"1year","weight":1.0276},{"period":"ytd","weight":0.8123}],"compareEarnings":[{"period":"1week","weight":0.0283},{"period":"1month","weight":0.0324},{"period":"3month","weight":0.0491},{"period":"6month","weight":0.1227},{"period":"1year","weight":0.1481},{"period":"ytd","weight":0.178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。该公司是一家生物制药公司,专注于收购和推进资产,通过产品收入、股权持有以及股息和特许权使用费收入流为股东提升长期价值。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.087937},{"month":2,"riseRate":0.6,"avgChangeRate":0.010779},{"month":3,"riseRate":0.4,"avgChangeRate":-0.009436},{"month":4,"riseRate":0.4,"avgChangeRate":-0.006403},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.025034},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.018965},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.008162},{"month":8,"riseRate":0.545455,"avgChangeRate":0.05815},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.057104},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.163485},{"month":11,"riseRate":0.818182,"avgChangeRate":0.114632},{"month":12,"riseRate":0.545455,"avgChangeRate":0.076763}],"exchange":"NASDAQ","name":"Fortress Biotech Inc.","nameEN":"Fortress Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fortress Biotech Inc.,FBIO,Fortress Biotech Inc.股票,Fortress Biotech Inc.股票老虎,Fortress Biotech Inc.股票老虎国际,Fortress Biotech Inc.行情,Fortress Biotech Inc.股票行情,Fortress Biotech Inc.股价,Fortress Biotech Inc.股市,Fortress Biotech Inc.股票价格,Fortress Biotech Inc.股票交易,Fortress Biotech Inc.股票购买,Fortress Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}